Team:CSWProteens/notebook

From 2014hs.igem.org

(Difference between revisions)

Revision as of 05:13, 12 June 2014

LAB NOTEBOOK

4/27 This weekend we made stock solutions of antibiotic solutions, prepared sterile LB agar plates supplemented with ampicillin, chloramphenicol, and the combination. We also prepared SOB broth for growing up transformed bacteria. Consequently, we are ready now to begin assembly of our device. 4/29 Today we transformed competent NEB-10 Beta Cells with pLG575 (secretion plasmid) to have a large supply of plasmid obtainable by mini-prep. 4/30 We took the gBlocks of parts A and B of the expression plasmid and the linearized plasmid pSB3A1 and digested the prefix and suffix of each with restriction enzymes: EchoRI, SpeI, Xbal, PstI, PslI. These enzymes recognize restriction sites and cut them in ways that allow part A to fuse with part B and for the fusion of A-B to fit into pSB3A1. The next step is to permanently ligate the parts so that we end up with a circular plasmid carrying the fusion part. The ligation will be performed on Thursday morning between 10 am and 1 pm. 5/1 Yesterday we cut Parts A and B and pSB3A1 so that they would would together. Today, we ligated the parts into our expression plasmid; T7 promoter RBS RiAFP 6xHis HlyA double terminator. The next step is to transform NEB-10 Beta competent cells with the plasmid.

@@ Line 106: / Line 106: @@
 <center><b>4/29</b></center>
 Today we transformed competent NEB-10 Beta Cells with pLG575 (secretion plasmid) to have a large supply of plasmid obtainable by mini-prep.
+<center><b>4/30</b></center>
+We took the gBlocks of parts A and B of the expression plasmid and the linearized plasmid pSB3A1 and digested the prefix and suffix of each with restriction enzymes: EchoRI, SpeI, Xbal, PstI, PslI. These enzymes recognize restriction sites and cut them in ways that allow part A to fuse with part B and for the fusion of A-B to fit into pSB3A1. The next step is to permanently ligate the parts so that we end up with a circular plasmid carrying the fusion part. The ligation will be performed on Thursday morning between 10 am and 1 pm.
+<center><b>5/1</b></center>
+Yesterday we cut Parts A and B and pSB3A1 so that they would would together. Today, we ligated the parts into our expression plasmid; T7 promoter RBS RiAFP 6xHis HlyA double terminator.  The next step is to transform NEB-10 Beta competent cells with the plasmid.